Zobrazeno 1 - 10
of 19
pro vyhledávání: ''
Autor:
Hedvig Björkestrand, Signe Friesland, Anna-Maja Svärd, Simon Ekman, Mikael Johansson, Andreas Hallqvist, Stefan Bergström, Erik Lundin, Erik Holmberg, Jan Nyman
Publikováno v:
Lung Cancer. 122:180-186
Objectives Concurrent chemoradiotherapy is the mainstay treatment for NSCLC stage III disease. To investigate whether radiation dose escalation based on individual normal tissue constraints can improve outcome, the Swedish lung cancer study group lau
Publikováno v:
Lung Cancer. 89:197-202
Introduction Non-small cell lung cancer (NSCLC) is the leading global cause of cancer death. While bone metastases (BM) commonly cause morbidity, bone-targeted agent (BTA) use is variable. We investigated the incidence and impact of BM among unselect
Autor:
Jun-ichi Saitoh, Yosuke Kamide, Katsuyuki Shirai, Masaki Nishioka, Yasuhiko Koga, Yoshio Tomizawa, Noriaki Sunaga, Akihiro Ono, Masana Matsuura, Akihiro Yoshii, Kyoichi Kaira, Takashi Nakano, Takeshi Ebara, Takeshi Hisada, Reiko Yoshino, Tamotsu Ishizuka, Yasuki Iwasaki
Publikováno v:
Lung Cancer. 82:449-454
Purpose To determine the efficacy and safety of oral S-1 in combination with cisplatin and thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer (NSCLC). Methods and materials S-1 (50 mg/m 2 ) was administered orall
Autor:
Jerzy Jakubowicz, Tomasz Walasek, Teresa Kowalska, Marian Reinfuss, Pawel Blecharz, Piotr Skotnicki, Anna Mucha-Małecka
Publikováno v:
Lung Cancer. 71:344-349
Purpose To present our experience with short-time, split-course palliative thoracic radiotherapy (PTR) in patients with advanced non-small cell lung cancer (NSCLC) with special regard to palliation of symptoms, tolerance and toxicity of PTR treatment
Publikováno v:
Lung Cancer. 63:387-392
Introduction For the induction therapy of non-small-cell lung cancer, we need to look for a regimen which produces a reliable high response rate with a low treatment related morbidity and mortality. Methods Patients in clinical stages IB, IIA and B,
Publikováno v:
Lung Cancer. 63:393-399
The purpose of this study was to evaluate the efficacy of oral glutamine in the prevention of acute radiation-induced esophagitis (ARIE) and weight loss in lung carcinoma patients, and to determine the clinical/dosimetric predictors of ARIE.Data from
Autor:
Marta Capellan, M. Luque, Noemi Villanueva, I. Muñiz, Jose-Luis de Sande, Angel J. Lacave, J. Buesa, Beatriz Mareque, Emilio Esteban, Yolanda Fernández, José-Luis Fernandez, Norberto Corral, Jose María Vieitez, Paula Jimenez, Joaquin Fra, E. Estrada
Publikováno v:
Lung Cancer. 55:173-180
To evaluate possible improvement in objective response of adding vinorelbine (V) to the combination of cisplatin/gemcitabine (CG) in induction chemotherapy for stage III NSCLC, patients (n=154) agedor =75 years, Karnofsky indexor =70%, were stratifie
Autor:
Sol San José, Maria Dolores Arnaiz, Ferran Guedea, Mariel Zaderazjko, Gala Serrano, Branislav Jeremic, Anna Lucas, V. Navarro
Publikováno v:
Lung Cancer. 52:149-154
Summary Background Radiation therapy (RT) alone is frequently used in elderly patients with medically inoperable early stage (I/II) non-small cell lung cancer (NSCLC). We retrospectively investigated the effectiveness of RT alone in this patient popu
Autor:
Grethe Lauvvang, Mari Wang, Reidulv Hatlevoll, Steinar Aamdal, Randi Berg, Kristin Øwre, P. Brunsvig
Publikováno v:
Lung Cancer. 50:97-105
Summary This Phase I/II study investigated weekly docetaxel (Taxotere ® ) with concurrent radiotherapy in 42 patients with untreated stage III non-small cell lung cancer (NSCLC). All patients were treated with chest irradiation: 2Gy administered 5 d
Publikováno v:
Lung Cancer. 44:213-220
Study objectives: To determine the outcome of patients with pulmonary typical and atypical carcinoid tumors treated with chemotherapy with or without radiotherapy. Methods: Patients with pulmonary neuroendocrine tumors treated at our institution from